Glioblastoma Multiforme

Showing NaN - NaN of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The PALSUR-study: Palliative Care Versus Surgery in High-grade

Recruiting
  • Glioblastoma
  • +3 more
  • Palliative Care
  • +2 more
  • San Francisco, California
  • +7 more
Nov 18, 2023

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma

Recruiting
  • Glioblastoma
  • +4 more
  • Tumor resection
  • Tumor biopsy
  • San Francisco, California
  • +7 more
Nov 18, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

    Recruiting
    • Glioblastoma
    • +3 more
    • Nivolumab-Placebo
    • +4 more
    • Los Angeles, California
    • +3 more
    Jan 16, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    High Grade Glioma, Glioblastoma Multiforme Trial in Japan, United States (DSP-0390)

    Recruiting
    • High Grade Glioma
    • Glioblastoma Multiforme
    • San Francisco, California
    • +8 more
    Dec 16, 2022

    Glioblastoma Multiforme Trial in United States (ERAS-801)

    Recruiting
    • Glioblastoma Multiforme
    • Los Angeles, California
    • +6 more
    Nov 14, 2022

    Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

    Active, not recruiting
    • Glioblastoma Multiforme
    • VBI-1901
    • +2 more
    • Los Angeles, California
    • +3 more
    Jun 27, 2022

    Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

    Not yet recruiting
    • Glioblastoma Multiforme
    • Glioblastoma
    • IGV-001 Cell Immunotherapy
    • +3 more
    • Newark, Delaware
    • +22 more
    Jun 24, 2022

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022

    Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

    Recruiting
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +17 more
    Apr 1, 2022

    Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)

    Completed
    • Glioblastoma Multiforme
    • Anaplastic Oligoastrocytoma
    • Los Angeles, California
    • +5 more
    Sep 21, 2021

    Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

    Completed
    • Gastric Adenocarcinoma
    • +15 more
    • Sacituzumab Govitecan-hziy (SG)
    • Aurora, Colorado
    • +11 more
    Aug 10, 2021

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed Trial in United States (Interferon-beta)

    Completed
    • Glioblastoma Multiforme
    • +3 more
    • Interferon-beta
    • Birmingham, Alabama
    • +4 more
    Nov 13, 2020

    Glioblastoma Multiforme Trial in Israel, United States (VB-111, Bevacizumab)

    Completed
    • Glioblastoma Multiforme
    • Boston, Massachusetts
    • +3 more
    Apr 23, 2020

    Glioblastoma Multiforme, GBM Trial in Boston (18F-FET)

    Completed
    • Glioblastoma Multiforme
    • GBM
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Oct 25, 2019

    Glioblastoma Multiforme Trial in United States (poly ICLC, temozolomide, radiation therapy)

    Completed
    • Glioblastoma Multiforme
    • poly ICLC
    • +2 more
    • Birmingham, Alabama
    • +8 more
    May 30, 2019

    Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)

    Completed
    • Glioblastoma Multiforme
    • Cilengitide 500 mg
    • Cilengitide 2000 mg
    • Birmingham, Alabama
    • +16 more
    Jan 18, 2019

    Glioblastoma Multiforme, Gliosarcoma Trial in United States (ZD6474, temozolomide, Radiation Therapy)

    Completed
    • Glioblastoma Multiforme
    • Gliosarcoma
    • Boston, Massachusetts
    • +6 more
    Feb 14, 2019

    Glioblastoma, GBM, Glioblastoma Multiforme Trial in Boston, Detroit, Cleveland (PF-00299804)

    Completed
    • Glioblastoma
    • +2 more
    • Boston, Massachusetts
    • +3 more
    Aug 14, 2018

    Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)

    Suspended
    • Glioblastoma Multiforme
    • ICT-107
    • Placebo
    • Birmingham, Alabama
    • +64 more
    Aug 9, 2018

    Head and Neck Squamous Cell Carcinoma, NSCLC, Triple Negative Breast Cancer Trial in Boston, San Antonio, Madrid (ABBV-221)

    Terminated
    • Head and Neck Squamous Cell Carcinoma
    • +4 more
    • Boston, Massachusetts
    • +4 more
    Mar 28, 2018

    Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid

    Completed
    • Adult Brain Glioblastoma
    • Glioblastoma Multiforme
    • SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
    • Bevacizumab
    • Birmingham, Alabama
    • +15 more
    Jan 24, 2018

    Glioblastoma Multiforme Trial in United States (Amgen 386, Bevacizumab)

    Completed
    • Glioblastoma Multiforme
    • Los Angeles, California
    • +5 more
    Jun 4, 2017